Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019-Reference-Cited by-同舟云学术

Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019

Author:

Duchesneau Emilie D.¹^ORCID,Kinlaw Alan C.²³^ORCID,Jonsson Funk Michele¹,Pate Virginia¹,Lund Jennifer L.¹^ORCID

Affiliation:

1. Department of Epidemiology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Division of Pharmaceutical Outcomes and Policy University of North Carolina School of Pharmacy Chapel Hill North Carolina USA

3. Cecil G. Sheps Center for Health Services Research University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Funder

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

Reference20 articles.

4. Pregnancy and the use of disease‐modifying therapies in patients with multiple sclerosis: benefits versus risks;Alroughani R;Mult Scler Int,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献